Indeed, the ACE2/Ang (1–7)/Mas receptor pathway is a potential therapeutic target worth exploring for ameliorating allergic inflammation of the respiratory tract, respiratory airway remodeling, and airway hyperresponsiveness. The gene discussed is ACE2; the disease is airway hyperresponsiveness.